Alpha Teknova (NASDAQ:TKNO) Research Coverage Started at Craig Hallum

Craig Hallum began coverage on shares of Alpha Teknova (NASDAQ:TKNO) in a research report sent to investors on Monday morning, MarketBeat reports. The firm issued a buy rating and a $12.00 target price on the stock.

Alpha Teknova Stock Performance

TKNO opened at $8.05 on Monday. Alpha Teknova has a 52-week low of $1.15 and a 52-week high of $10.37. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73. The company has a market cap of $429.15 million, a PE ratio of -10.88 and a beta of 0.34. The stock has a 50-day moving average of $8.48 and a 200-day moving average of $6.54.

Hedge Funds Weigh In On Alpha Teknova

Large investors have recently made changes to their positions in the business. State Street Corp raised its holdings in Alpha Teknova by 249.3% in the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after acquiring an additional 54,700 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Alpha Teknova in the 3rd quarter worth $1,483,000. Roubaix Capital LLC bought a new position in shares of Alpha Teknova in the 3rd quarter worth $2,015,000. Geode Capital Management LLC raised its stake in Alpha Teknova by 24.4% during the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock worth $911,000 after buying an additional 36,914 shares during the period. Finally, China Universal Asset Management Co. Ltd. acquired a new stake in Alpha Teknova during the 4th quarter worth $94,000. Institutional investors and hedge funds own 13.81% of the company’s stock.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.